Literature DB >> 6417015

Activation of murine B lymphocytes by Neisseria meningitidis and isolated meningococcal surface antigens.

J Melancon, R A Murgita, I W Devoe.   

Abstract

Heat-killed Neisseria meningitidis was found to be a potent mitogen for mouse splenic lymphocytes. Results obtained with different cell separation techniques indicated that the bacteria acted to selectively induce proliferation of B lymphocytes. First, partial or total depletion of T lymphocytes by treatment with various anti-T-cell antisera plus complement did not affect the ability of the remaining spleen cells to proliferate in response to N. meningitidis. Second, T lymphocytes purified by affinity chromatography through an immunoglobulin-antiimmunoglobulin-coated glass bead column were unresponsive to meningococcal stimulation, even when provided with a source of macrophages (irradiated or mitomycin C-treated spleen cells). Finally, treatment of spleen cells with soy bean agglutinin showed that, whereas the soy bean agglutinin-positive population (B-enriched lymphocytes) was highly responsive to stimulation by N. meningitidis, the soy bean agglutinin-negative population (T-enriched lymphocytes) displayed only a background level of proliferation when exposed to the bacteria. Isolated meningococcal surface antigens such as lipopolysaccharide (LPS) and outer membranes also possessed mitogenic activity and induced proliferation of B lymphocytes in a dose-dependent manner. Both LPS and non-LPS components contributed to the mitogenicity of outer membranes since the addition of outer membrane preparations to spleen cells from the low LPS responder C3H/HeJ mouse strain gave rise to a high level of proliferative activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417015      PMCID: PMC264453          DOI: 10.1128/iai.42.2.471-479.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  Gamma-M deficiency predisposing to meningococcal septicaemia.

Authors:  J R Hobbs; R D Milner; P J Watt
Journal:  Br Med J       Date:  1967-12-09

2.  Energy-independent uptake of iron from citrate by isolated outer membranes of Neisseria meningitidis.

Authors:  C Simonson; T Trivett; I W DeVoe
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

3.  Prevention of meningococcal disease by group C polysaccharide vaccine.

Authors:  M S Artenstein; R Gold; J G Zimmerly; F A Wyle; H Schneider; C Harkins
Journal:  N Engl J Med       Date:  1970-02-19       Impact factor: 91.245

4.  Cellular immunity in patients with meningococcal disease and in vaccinated subjects.

Authors:  B M Greenwood; A J Oduloju; M A Ade-Serrano
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

5.  Meningococcal infections. 5. Duration of polysaccharide-vaccine-induced antibody.

Authors:  M S Artenstein
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

6.  Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70.

Authors:  R Gold; M S Artenstein
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

7.  Meningococcal infections. 3. Studies of group A polysaccharide vaccines.

Authors:  M S Artenstein; W C Branche; J G Zimmerly; R L Cohen; E C Tramont; D L Kasper; C Harkins
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

8.  Antibody-dependent mononuclear cell-mediated antimeningococcal activity. Comparison of the effects of convalescent and postimmunization immunoglobulins G, M, and A.

Authors:  G H Lowell; L F Smith; J M Griffiss; B L Brandt; R P MacDermott
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

9.  Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.

Authors:  E C Gotschlich; I Goldschneider; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

10.  Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state.

Authors:  E C Gotschlich; I Goldschneider; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  10 in total

1.  Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine.

Authors:  F Oftung; L M Naess; L M Wetzler; G E Korsvold; A Aase; E A Høiby; R Dalseg; J Holst; T E Michaelsen; B Haneberg
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

2.  Immunoresponses to Neisseria meningitidis epitopes: primary versus secondary antiphosphorylcholine responses.

Authors:  J Faro; R Seoane; E Puentes; F Martínez Ubeira; B J Regueiro
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

3.  Human T-cell responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine.

Authors:  L M Naess; F Oftung; A Aase; L M Wetzler; R Sandin; T E Michaelsen
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  N-linked oligosaccharides of human transferrin are not required for binding to bacterial transferrin receptors.

Authors:  J S Padda; A B Schryvers
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

5.  T-cell modulation of the antibody response to bacterial polysaccharide antigens.

Authors:  C E Taylor; R Bright
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

6.  A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants.

Authors:  R W Tindle; S Croft; K Herd; K Malcolm; A F Geczy; T Stewart; G J Fernando
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

7.  Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin.

Authors:  Heather MacLeod; Navneet Bhasin; Lee M Wetzler
Journal:  Clin Vaccine Immunol       Date:  2008-02-20

8.  Activation of rat B lymphocytes by Actinobacillus actinomycetemcomitans.

Authors:  H Yoshie; M A Taubman; J L Ebersole; C L Olson; D J Smith; J Pappo
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

9.  Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants.

Authors:  G H Lowell; L F Smith; R C Seid; W D Zollinger
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

10.  Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate.

Authors:  L M Wetzler; Y Ho; H Reiser; L W Wetzler
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.